Glaxo Shines On Advair News But Ftse Edged Lower
Source: Guardian
Thursday 18th March, 2010
has been in demand all day as the prospect of imminent competition to its best selling drug Advair in the US appeared to recede.Rival Novartis has relinquished American rights to a generic version of ... ...
Read the full story at
Guardian
Email this story to a friend
Have your say on this story